OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ABUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ABUS is expected to report earnings to fall 550.00% to -4 cents per share on November 05

Arbutus Biopharma ABUS Stock Earnings Reports

Q3'25

Est.

$-0.05

Q2'25

Beat

by $0.05

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.01

The last earnings report on August 06 showed earnings per share of 0 cents, beating the estimate of -3 cents. With 36.03K shares outstanding, the current market capitalization sits at 651.78M.

View a ticker or compare two or three

Compare

ABUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABUS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABUS showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

701 Veterans Circle

Phone

+1 267 469-0914

Employees

Web

http://www.arbutusbio.com